The problem with relying on other countries

For a long time, the story of medicine across the continent has been defined by a cycle of ordering and waiting. Africa currently faces 25% of the global health challenges, yet the continent continues to purchase nearly 70% to 90% of its pharmaceutical supplies from external sources. This reliance creates a significant obstacle preventing the continent from maintaining meaningful control over its own public health outcomes.

The dangers of this dependency became undeniable during the COVID-19 pandemic when global supplies ran low and African nations were frequently pushed to the back of the line and became the last to receive lifesaving vaccines. This situation revealed a difficult truth: relying on others for survival is a massive risk particularly because when supply chains break ,people begin to suffer. This reality is especially harsh for families in rural areas who often wait months for basic medication.

An action plan from the World Economic Forum indicates that a major shift is finally occurring. Africa is moving away from being a mere consumer of medicine and is starting to build the necessary factories to produce these goods at home, which is a vital component of the broader plan to expand the continental economy by 2030.

Making medicine can grow the economy

Producing medicine is about far more than health since it provides jobs and hope in a region where half of the population currently cannot access basic treatments. The WEF report identifies the pharmaceutical sector as one of four areas with high potential, and experts project this market will be worth $75 billion by 2030 ,a significant jump from current factories that mostly just pack pills into bottles. To achieve true growth, the continent must transition into manufacturing the actual Active Pharmaceutical Ingredients (APIs).

German biotech giant BioNTech has taken a significant step toward its ambitious goal of producing mRNA vaccines in Africa by setting up the first BioNTainer at its manufacturing facility in Kigali, Rwanda. (Image Rights: Empower Africa)

Engaging in this higher level of production creates high quality jobs for young scientists, engineers, and technology experts while simultaneously supporting local schools. Universities will need to expand their programs to train more pharmacists and lab technicians, turning a health need into a boost for every family and moving Africa up the global value chain. This transformation creates a ripple effect in the economy because when a factory opens, it requires builders, drivers, and security, ensuring more money stays within African communities as the continent moves from consumer to creator.

Joining forces to create a giant market

A new trade agreement, the AfCFTA is making this industrialization possible, overcoming past hurdles where a single country lacked enough customers to sustain a factory. While a factory in a small nation might have run out of buyers quickly, this agreement now connects 54 countries into one giant market of 1.7 billion people which serves as a central pillar of the WEF Action.

This change is a total game changer for business because a factory in Kenya can now sell its products to the entire continent. This is without extra taxes at every border making Africa highly attractive to major investors, who the environment encourages to construct local factories designed to serve everyone.

Consumer spending in this market is expected to reach $6.7 trillion by 2030, allowing for pills to be shipped from a neighboring country rather than halfway across the world. This approach saves both time and money while making supply chains much more resilient against global shocks.

Creating rules that everyone can trust

The continent is currently modernizing its regulatory framework to move away from a confusing past where companies were required to apply for 54 different permits just to sell a single pill. New organizations, such as the African Medicines Agency, are now assisting by establishing a single high standard for regulatory harmony to ensure that “Made in Africa” becomes a label synonymous with top tier quality.

Because patients need to know their medicine is safe and effective, the Africa CDC is helping countries buy in bulk to lower pharmacy prices while providing local factories with the steady orders needed to scale up and hire more people. This strategy, which acts like a large group of neighbours buying food together to get a discount, is a key commitment highlighted in the WEF report as a way to ensure factories can afford to grow.

Solving the problem of high costs

One of the largest hurdles for African families is the high cost of medical care, as out-of-pocket spending is often so significant that a single illness can push a household into poverty. Local manufacturing addresses this crisis by eliminating expensive international shipping and reducing the financial impact of fluctuating currency exchange rates.

When costs are lower, more people can afford to finish their full course of treatment, this isn’t just about feeling better it’s about preventing drug resistant strains like Malaria and TB which are significantly more lethal and expensive to treat than the original infection. Furthermore, local factories can focus on the specific treatments the population needs most, producing medicine for local diseases that large global companies might otherwise ignore to ensure health remains a right for everyone rather than a luxury.

Building a future where Africa stands tall

The ability to manufacture medicine is a matter of both pride and safety because it ensures the continent will not have to wait for external help during the next global crisis. Progress is already visible with new vaccine plants opening in Rwanda and Senegal, serving as symbols of a new era that proves the continent can handle the most advanced technology in the world.

A 10-year roadmap for health security is now in place, and the 2024 Action Plan demonstrates that the foundation is ready for leaders to ensure no child goes without a vaccine because of their place of birth. A system is being built to protect both grandparents and children, shifting the focus from whether Africa will lead to who will be the first to join this movement. By working together, a history of dependence can finally be transformed into a future defined by strength and health.

A Self-Reliant Future

Ultimately, shifting Africa from a consumer to a producer of pharmaceuticals is a vital step toward securing both the continent’s health and its economic future. By leveraging the massive unified market of the AfCFTA and modernizing regulatory standards, the continent is overcoming the dependencies that left it vulnerable during past global crises.

Manufacturing medicine locally does more than just provide essential treatments for local diseases; it fuels industrial growth, creates high quality jobs for a new generation of experts, and lowers costs for families. As Africa builds the factories and frameworks necessary to sustain itself, it moves away from a history of waiting and toward a future of strength, health security, and technological pride.